Mounjaro® Weight Loss Program in Chandler, Gilbert & Mesa, Arizona

---

What Makes Mounjaro® Different: The Dual Receptor Advantage

Most GLP-1 medications work on a single hormone receptor. Mounjaro® (tirzepatide) is a first-in-class dual agonist—it activates both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual action targets weight and metabolic health from two complementary directions simultaneously.

GLP-1 Receptor Activation

Like semaglutide-based medications, tirzepatide’s GLP-1 activity slows gastric emptying so you feel full longer, suppresses hunger signaling in the hypothalamus to reduce food noise and cravings, and stimulates insulin release proportionally to blood sugar levels while limiting excess liver glucose output.

GIP Receptor Activation — The Key Differentiator

GIP is a second gut hormone that works in synergy with GLP-1. GIP receptor activation enhances the insulin response further, improves insulin sensitivity in fat tissue, and may reduce the gastrointestinal side effects that some patients experience with GLP-1-only medications. Clinical evidence suggests the dual mechanism produces significantly greater weight loss than either receptor targeted alone.

The Clinical Result

In the SURPASS clinical trial program, Mounjaro® produced average weight reductions of 15–22% of total body weight—results that exceeded those seen in trials for GLP-1-only medications and represent some of the most compelling weight loss outcomes ever recorded for a pharmaceutical intervention.

---

How Mounjaro® Works in Your Body

Tirzepatide’s dual receptor mechanism produces four key physiological effects that together create a powerful, sustained weight loss environment:

1. Prolonged Satiety After Meals

By slowing gastric emptying, Mounjaro® keeps food in the stomach longer—extending the sensation of fullness well beyond what a meal would normally provide. Most patients find portion control and intermeal restraint become effortless rather than a constant struggle.

2. Powerful Appetite Suppression

The dual receptor effect produces a stronger reduction in hunger signaling than GLP-1 alone. Patients consistently report a dramatic quieting of “food noise”—the persistent mental preoccupation with eating—which fundamentally changes the psychological experience of dieting.

3. Superior Glycemic Control

Both GLP-1 and GIP receptors contribute to insulin regulation. Tirzepatide produces exceptional blood sugar stabilization—reducing the energy crashes, mood disruptions, and reactive cravings that stem from glycemic instability. This is particularly impactful for patients with Type 2 diabetes, prediabetes, or insulin resistance.

4. Improved Metabolic & Cardiovascular Markers

Clinical data demonstrates meaningful reductions in blood pressure, LDL cholesterol, triglycerides, and waist circumference beyond what weight loss alone would predict. For many East Valley patients, these downstream metabolic gains are as clinically significant as the number on the scale.

---

Why Chandler, Gilbert & Mesa Patients Choose New Viva MD

General med-spas and online GLP-1 subscription services can issue a prescription. They cannot replicate the safety, personalization, and accountability of a physician-supervised practice with a real doctor overseeing every step of your care.

Board-Certified Physician Oversight

Your care is directed by a licensed MD—not a mid-level provider or a remote algorithm. Mounjaro® is a potent dual-receptor medication; precise dose titration and medical supervision are especially important to minimize side effects and maximize outcomes.

True Personalization, Not a Template

We evaluate your complete health picture before prescribing—including lab work, medication interactions, metabolic history, and co-existing conditions. Your protocol is built around your specific physiology, not a one-size-fits-all dosing schedule.

Integrated Lifestyle Support

Medication is a catalyst, not a cure. We pair every Mounjaro® prescription with nutritional guidance and behavioral coaching designed to build habits that outlast treatment—making your results sustainable long after active therapy ends.

Conveniently Located for East Valley Patients

Our office at 2390 West Ray Road in Chandler is minutes from Gilbert and Mesa. You receive physician-grade metabolic care without traveling to Scottsdale or central Phoenix.

Precision Dose Management

Mounjaro® is titrated slowly from a low starting dose to minimize gastrointestinal side effects. Our physician manages this process carefully—adjusting your schedule based on your individual tolerance and response, not a generic protocol.

Transparent Cost & Insurance Guidance

We walk every patient through cost expectations, coverage realities for tirzepatide, and available manufacturer savings programs during your initial consultation. No surprise billing. See newvivamd.com/cost-and-insurance/ for details.

---

Benefits of the New Viva MD Mounjaro® Program

When dual receptor therapy is paired with physician supervision and lifestyle coaching, the benefits extend well beyond the scale:

• Superior Weight Loss Outcomes: SURPASS trial data shows 15–22% total body weight reduction—among the highest results ever recorded for a pharmaceutical weight loss intervention.
• Stronger Appetite Suppression: The dual GIP+GLP-1 mechanism produces greater reduction in hunger and food noise than GLP-1-only medications, making sustained calorie reduction significantly easier.
• Exceptional Glycemic Control: Particularly effective for patients with Type 2 diabetes, prediabetes, or insulin resistance—stabilizing blood sugar and reducing A1C meaningfully.
• Improved Metabolic Markers: Reductions in blood pressure, LDL cholesterol, and triglycerides beyond what weight loss alone predicts, with cardiovascular risk benefits documented in clinical trials.
• Reduced GI Side Effects vs. GLP-1 Only: Some patients tolerate tirzepatide better than semaglutide alone, as the GIP component may buffer gastrointestinal effects during titration.
• Increased Energy & Mobility: As weight decreases, patients report significant gains in daily energy, joint comfort, sleep quality, and motivation to engage in physical activity.
• Durable Lifestyle Habits: With hunger and cravings managed medically, you have the cognitive bandwidth to build the nutritional and behavioral habits that sustain results long-term.
• Physician-Monitored Safety: Regular check-ins ensure the medication remains safe and effective throughout your treatment course, with dose adjustments as needed.

---

Is Mounjaro® Right for You?

During your consultation, our physician conducts a thorough medical evaluation to confirm candidacy. The following is a general overview of qualification criteria.

Strong Candidates

• BMI of 30 or above
• BMI 27+ with weight-related conditions such as Type 2 diabetes, hypertension, sleep apnea, or prediabetes
• Patients who have tried GLP-1-only medications (e.g., Ozempic®, Wegovy®) and seek stronger results
• Patients with Type 2 diabetes seeking combined glycemic control and weight management
• No known allergy or sensitivity to tirzepatide or GIP/GLP-1 receptor agonists
• Willingness to engage with lifestyle modifications alongside medication
• Age 18 and older

Not Currently Eligible

• Personal or family history of medullary thyroid carcinoma (MTC)
• Personal or family history of Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• History of pancreatitis
• Current pregnancy or active breastfeeding
• Known hypersensitivity to tirzepatide or any component of the formulation
• Under 18 years of age

Note: This is general guidance only. Final candidacy is determined by physician evaluation. Lab work and other diagnostics may be ordered as part of your assessment.

---

What to Expect at New Viva MD

From your first call to long-term follow-up, every step is designed around your safety and success.

Step 1: Comprehensive Consultation

Your physician reviews your full health history, current medications, metabolic markers, and prior weight loss attempts. A physical exam and body composition analysis is completed. If you have previously used Ozempic® or another GLP-1 medication, we evaluate your response and determine whether tirzepatide’s dual mechanism represents a better clinical fit. All questions are answered with no pressure and no obligation.

Step 2: Personalized Treatment Plan

If Mounjaro® is appropriate for you, we build a protocol around your starting dose and titration schedule. Mounjaro® is initiated at 2.5 mg weekly and increased gradually to the lowest effective dose—typically between 5 mg and 15 mg—to minimize gastrointestinal side effects while maximizing weight loss. The once-weekly subcutaneous injection uses an ultra-fine pen needle and is near-painless for most patients.

Step 3: Ongoing Monitoring & Refinement

Scheduled follow-up appointments track your progress, address any side effects, and adjust dosing as needed. Your physician remains your accountability partner throughout the entire treatment course. Lab values, blood sugar, blood pressure, and relevant conditions are re-evaluated as your weight changes.

---

Mounjaro® vs. Other Weight Loss Medications

Multiple GLP-1 and dual-receptor medications are available today. Here is how they compare clinically. We help you identify the best fit during your consultation.

Feature	Mounjaro® (Tirzepatide)	Ozempic® (Semaglutide)	Wegovy® (Semaglutide)
FDA Approval	Type 2 Diabetes (off-label for weight loss)	Type 2 Diabetes (off-label for weight loss)	Weight Management
Mechanism	GLP-1 + GIP Dual Receptor Agonist	GLP-1 Receptor Agonist	GLP-1 Receptor Agonist
Dosing	Once weekly injection	Once weekly injection	Once weekly injection
Max Dose	15 mg / week	2 mg / week	2.4 mg / week
Typical Weight Loss	15-22% body weight	10-15% body weight	12-17% body weight
Dual Hormone Action	Yes — GLP-1 & GIP	No — GLP-1 only	No — GLP-1 only
Insurance Coverage	Varies by plan	Varies by plan	Varies by plan
Best For	Patients seeking maximum weight loss or with T2D	First-line GLP-1 option	Higher semaglutide dose needed

Note: Medication selection is determined by individual clinical evaluation. Mounjaro® is FDA-approved for Type 2 diabetes and prescribed for weight loss as an off-label use. Zepbound® contains the same active ingredient (tirzepatide) and holds a separate FDA approval specifically for weight management. Ask your physician which is appropriate for your situation.

---

Mounjaro® vs. Zepbound®: What Is the Difference?

Patients are often surprised to learn that Mounjaro® and Zepbound® contain the same active ingredient: tirzepatide. The key distinction is their FDA-approved indication:

• Mounjaro®: FDA-approved for the treatment of Type 2 diabetes. When prescribed for weight loss in patients without diabetes, it is used off-label—a common, clinically appropriate practice.
• Zepbound®: FDA-approved specifically for chronic weight management in adults with a BMI ≥30 (or ≥27 with a weight-related condition).

During your consultation, our physician will determine which formulation and approval pathway is most appropriate for your specific health profile and insurance situation. Both deliver the same dual GIP+GLP-1 mechanism and clinical weight loss results.

---

Serving Chandler, Gilbert & Mesa, AZ

Our office is located in Chandler to serve patients across the East Valley with minimal commute.

Chandler (Main Office)

2390 West Ray Road #1, Chandler, AZ 85224  |  (480) 331-4316

Physician-led, dedicated to medical weight loss, aesthetics, and wellness. Easy access from the Loop 101 and Loop 202.

Gilbert Patients

Patients from Gilbert, San Tan Valley, and Queen Creek visit our Chandler office—minutes east via Chandler Boulevard or Ray Road. Approx. 10–15 minutes from central Gilbert.

Mesa Patients

South and East Mesa patients find our Chandler location far more accessible than clinics in central Phoenix or Scottsdale. Same physician-supervised standard of care, closer to home. Approx. 15–20 minutes from south Mesa.

---

Frequently Asked Questions